Literature DB >> 30150425

Association of Polymorphisms in DNA Repair Gene XRCC3 with Asthma in Taiwan.

Wan-Yun Hsiao1,2, Chia-Wen Tsai3, Wen-Shin Chang3,4, Shengyu Wang5, Che-Yi Chao6, Wei-Chun Chen2,7, Te-Chun Shen8,4, Te-Chun Hsia9,3,7, DA-Tian Bau8,4,10.   

Abstract

AIM: Accumulating evidence suggests that DNA damage and repair play a role in asthma etiology, however, little is known about the contribution of genotypes of DNA repair genes to asthma susceptibility. This study aimed to examine the contribution of genotypes of DNA double-strand break repair gene X-ray repair cross complementing protein 3 (XRCC3) and its polymorphisms to asthma risk in the Taiwanese.
MATERIALS AND METHODS: Associations of seven XRCC3 genotypes, namely rs1799794, rs45603942, rs861530, rs3212057, rs1799796, rs861539 and rs28903081, with the risk of asthma were investigated among 198 patients with asthma and 453 non-asthma controls by polymerase chain reaction-restriction fragment length polymorphism genotyping methodology.
RESULTS: Unlike Caucasian populations, no polymorphic genotypes at XRCC3 rs3212057 or rs28903081 were found among the Taiwanese. For the genotypes of XRCC3 rs1799794, rs45603942, rs861530, rs1799796 and rs861539, the percentages of hetero-and homo-variant genotypes were not differentially represented between the asthma patient and the non-asthma control groups. In addition, there was no differential distribution of allelic frequencies for these XRCC3 polymorphic sites between the two groups. No interaction of these genotypes with gender or age were found.
CONCLUSION: Although XRCC3 plays a role in asthma etiology, the variant XRCC3 genotypes do not serve as practicable predictive markers for asthma risk in Taiwanese. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Asthma; Taiwan; XRCC3; genotype; single nucleotide polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30150425      PMCID: PMC6199602          DOI: 10.21873/invivo.11344

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  34 in total

1.  Contribution of double strand break repair gene XRCC3 genotypes to nasopharyngeal carcinoma risk in Taiwan.

Authors:  Juhn-Cherng Liu; Chia-Wen Tsai; Chin-Mu Hsu; Wen-Shin Chang; Chi-Yuan Li; Shih-Ping Liu; Wu-Chung Shen; Da-Tian Bau
Journal:  Chin J Physiol       Date:  2015-02-28       Impact factor: 1.764

2.  DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4⁺ T-cell function without causing severe combined immunodeficiency.

Authors:  Mohamed A Ghonim; Kusma Pyakurel; Jihang Ju; Paulo C Rodriguez; Matthew R Lammi; Christian Davis; Mohammad Q Abughazleh; Moselhy S Mansy; Amarjit S Naura; A Hamid Boulares
Journal:  J Allergy Clin Immunol       Date:  2014-10-19       Impact factor: 10.793

3.  Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan.

Authors:  Z Qureshi; I Mahjabeen; Rm Baig; Ma Kayani
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma.

Authors:  Wanxing Eugene Ho; Chang Cheng; Hong Yong Peh; Fengguo Xu; Steven R Tannenbaum; Choon Nam Ong; W S Fred Wong
Journal:  Free Radic Biol Med       Date:  2012-05-23       Impact factor: 7.376

5.  The Contribution of Interleukin-10 Promoter Genotypes to Susceptibility to Asthma in Adults.

Authors:  Te-Chun Hsia; Wen-Shin Chang; Shengyu Wang; Te-Chun Shen; Wan-Yun Hsiao; Chin-Jung Liu; Shinn-Jye Liang; Wei-Chun Chen; Chih-Yen Tu; Chia-Wen Tsai; Chin-Mu Hsu; Da-Tian Bau
Journal:  In Vivo       Date:  2015 Nov-Dec       Impact factor: 2.155

6.  Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.

Authors:  Chen-Hsien Su; Wen-Shin Chang; Pei-Shin Hu; Chieh-Lun Hsiao; Hong-Xue Ji; Cheng-Hsi Liao; Te-Cheng Yueh; Chin-Liang Chuang; Chia-Wen Tsai; Chin-Mu Hsu; Hsien-Yuan Lane; Da-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2015 Nov-Dec       Impact factor: 4.069

Review 7.  5. Genetics of allergic disease.

Authors:  John W Steinke; Stephen S Rich; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2008-02       Impact factor: 10.793

8.  The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese.

Authors:  Shujie Guo; Xiaobo Li; Min Gao; Yuqiong Li; Bei Song; Wenquan Niu
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

Review 9.  Recent advances in asthma genetics.

Authors:  Jian Zhang; Peter D Paré; Andrew J Sandford
Journal:  Respir Res       Date:  2008-01-15

10.  Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women.

Authors:  Beata Smolarz; Marianna Makowska; Dariusz Samulak; Magdalena M Michalska; Ewa Mojs; Maciej Wilczak; Hanna Romanowicz
Journal:  Clin Exp Med       Date:  2014-04-13       Impact factor: 3.984

View more
  3 in total

1.  Genetic variants in miR-145 gene are associated with the risk of asthma in Taiwan.

Authors:  Shou-Cheng Wang; Chia-Wen Tsai; Wen-Shin Chang; Ning-Yi Hsia; Mei-Chin Mong; Yun-Chi Wang; Te-Chun Hsia; Jian Gu; Da-Tian Bau
Journal:  Sci Rep       Date:  2022-09-07       Impact factor: 4.996

2.  Significant Association of Cyclin D1 Promoter Genotypes With Asthma Susceptibility in Taiwan.

Authors:  Chia-Hsiang Li; Kuo-Liang Chiu; Te-Chun Hsia; Te-Chun Shen; Li-Hsiou Chen; Chien-Chih Yu; Mei-Chin Mong; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2021 Jul-Aug       Impact factor: 2.155

3.  Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.

Authors:  Li-Hsiou Chen; Kuo-Liang Chiu; Te-Chun Hsia; Yen-Hsien Lee; Te-Chun Shen; Chia-Hsiang Li; Yi-Cheng Shen; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.